Search

Search Results
Results 4731 - 4740 of 4752 for multiple sclerosis
  • Using Chinese hamster ovary cells as a bioprocessing tool
    White Paper - 16 Nov 2022
    This article describes the importance of Chinese Hamster Ovary cells (CHO cells) for scientific discovery and bioprocessing.
  • Natrilix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.
  • Natrilix
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix (indapamide) intended for persons living in Australia.
  • Odaplix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Odaplix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.
  • Prexum Combi
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Prexum Combi (perindopril and indapamide) intended for persons living in Australia.
  • Coversyl Plus
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • Prexum
    Drug - 15 Jul 2022
    Consumer Medicine Information (CMI) about Prexum (perindopril) intended for persons living in Australia.
  • Perindo
    Drug - 6 Jul 2022
    Consumer Medicine Information (CMI) about Perindo (perindopril) intended for persons living in Australia.
  • Tecfidera
    Drug - 6 Oct 2021
    Consumer Medicine Information (CMI) about Tecfidera (Dimethyl fumarate) intended for persons living in Australia.
  • An Analytical and Legal Spotlight on Cannabis
    White Paper - 9 Feb 2021
    This article will look at cannabis in relation to an analytical and leag standpoint.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback